Medicines: clinical trials hub
Legal framework, regulatory requirements, and supporting guidance needed to design, apply for, conduct, modify, close, and comply with UK legislation for clinical trials for medicines in the UK.
Clinical Trial Protocol Checker
Clinical Trial sponsors and their representatives can use this AI-powered tool to check their draft protocols for potential issues that could lead to Requests for Further Information (RFIs) prior to submission.
Checking your protocol saves time during assessment
The tool will check your protocol for possible causes of RFIs in four common clinical areas:
- Unblinding in case of an emergency
- Clinical eligibility criteria
- Contraceptive requirements
- Adverse event and serious adverse recording and reporting
Checking your protocol for potential issues in these categories and addressing them prior to submission may help reduce the likelihood of them being raised during assessment.
Registration for access to the AI tool is planned to open late November 2026, with a phased approach to onboarding.
Sign up to ‘Get emails about this page’ when more information is available.
UK Legislation
The Medicines for Human Use (Clinical Trials)(Amendment) Regulations 2025 came into force 28 April 2026.
The Medicines for Human Use (Clinical Trials)Regulations 2004
The Medicines for Human Use (Clinical Trials)(Amendment) Regulations 2025
The Human Medicines Regulations 2012
Regulatory Framework
Important Note: This guidance is designed to assist sponsors and investigators in complying with their duties in relation to clinical trials. This page includes links to pages containing general guidance only. It must not be regarded as a definitive interpretation of the Regulations or a substitute for the regulations.
The MHRA cannot provide a definitive interpretation of the law; only the courts can do this. If in doubt you should seek your own legal advice.
International guidance
Other relevant guidance
MHRA guidance
The amended Clinical Trials Regulations took full effect on 28 April 2026. As such, this guidance should now be considered effective and is no longer in draft.
Applying for clinical trial approval
IMPs & NIMPs
During the clinical trial
Making changes to trials
Ending a trial
Compliance
News and blogs
Payments and fees
Payments for DSUR submissions by credit or debit cards can be made via our payment centre.
Archived guidance
Access previous versions of MHRA Guidance from the UK Government Web Archive
Guidance - before 28 April 2026
Clinical Trials guidance that should be followed prior to 28 April 2026.